Ergo was Drdgold’s largest segment in fiscal 2026, bringing in $8.08B of $11.16B (72%).
| Segments [axis] | FY 2016 | FY 2017 | FY 2018 | FY 2022 | FY 2023 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|
| Ergo | — | $5.67B | $8.08B | ||||
| Operating Segments | $4.11B | — | — | ||||
| Revenue | — | — | — | ||||
| Fwgr | — | $2.21B | $3.08B | ||||
| Total | $4.11B | $7.88B | $11.16B |
Drdgold brought in $11.16B from its two segments in fiscal 2026, the year ended June 30, 2026. That was up 41.6% from $7.88B in fiscal 2025. Ergo was the largest at $8.08B (72.4%), ahead of Fwgr at $3.08B (27.6%).
Compared with fiscal 2025, Ergo grew 42.5% to $8.08B and Fwgr grew 39.5% to $3.08B.
Drdgold began breaking out Ergo in fiscal 2025 and Fwgr in fiscal 2025. Drdgold stopped reporting Operating Segments as a separate segment after fiscal 2023, when it brought in $4.11B.
Drdgold (DRD) reports its revenue by segments [axis]. In fiscal 2026, Ergo was its largest segment, bringing in $8.08B (72.4% of the total), followed by Fwgr at $3.08B (27.6%).
Ergo was Drdgold's largest segment in fiscal 2026, bringing in $8.08B, or 72.4% of the $11.16B total across its two segments.
Ergo grew faster than Fwgr in fiscal 2026, up 42.5% from $5.67B to $8.08B. Fwgr grew 39.5% to $3.08B.
Every figure comes from Drdgold's annual financial filings, as reported. Each line keeps the name Drdgold gives it, and years follow its fiscal calendar.
Drdgold's revenue by segments [axis] goes back to fiscal 2016, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.